Etelcalcetide
Calcium-sensing receptor agonist for secondary hyperparathyroidism. Peptide calcimimetic reducing PTH secretion in chronic kidney disease patients on dialysis.
Etelcalcetide is a synthetic calcium-sensing receptor (CaSR) agonist, an eight-amino acid peptide containing D-amino acids, designed for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. It binds to and activates the CaSR on parathyroid cells, thereby reducing parathyroid hormone (PTH) secretion.
| Parameter | Specification |
| CAS | 1334237-71-6 |
| Category | Bone Health |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Secondary hyperparathyroidism, CKD-mineral bone disorder, dialysis patients |
| CAS | 1334237-71-6 |
|---|---|
| Applications | Treatment of secondary hyperparathyroidism (SHPT) in CKD patients on hemodialysis |




